Syndax Pharmaceuticals (SNDX) Capital Expenditures Growth (3y) (2018)

Syndax Pharmaceuticals (SNDX) Capital Expenditures Growth (3y) (2018) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (3y) (Qtr)
1 Oculis Holding AG 66,861.65 Bn 66,861.36 Bn - -
2 Nanobiotix 1,912.79 Bn 1,912.72 Bn - -
3 Akari Therapeutics 1,071.19 Bn 1,071.19 Bn - -
4 BeOne Medicines 469.11 Bn 464.32 Bn 1.35 Bn -12.25%
5 Vertex Pharmaceuticals 123.03 Bn 115.78 Bn 2.59 Bn 46.88%
6 Regeneron Pharmaceuticals 70.13 Bn 61.37 Bn 3.31 Bn 8.97%
7 Belite Bio 63.44 Bn 63.44 Bn - -
8 Argenx Se 55.97 Bn 50.78 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.53 Bn 34.52 Bn 959.66 Mn 16.27%
10 Syndax Pharmaceuticals 1.85 Bn 1.50 Bn 53.02 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2018 -23.28%